Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with β adrenergic antagonists

British Journal of Ophthalmology

Volumn 84, Issue 2, 2000, Pages 181-185

  Nordmann, Jean Philippe ^a   Söderström, Mats ^b   Rouland, Jean François ^c,d   Malecaze, François ^a  

^a CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LATANOPROST; PILOCARPINE; TIMOLOL; TIMOLOL MALEATE;

ADULT; AGED; ALLERGIC CONJUNCTIVITIS; ARTICLE; CIRCADIAN RHYTHM; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TOLERANCE; FEMALE; FRANCE; GLAUCOMA; HEADACHE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NIGHT VISION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL ANALYSIS; SWEDEN; VERTIGO; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; DRUG COMBINATIONS; FEMALE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; MIOTICS; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; PILOCARPINE; PROSTAGLANDINS F, SYNTHETIC; TIMOLOL;

EID: 1642633575     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.84.2.181     Document Type: Article

References (17)

1. Alm A, Widengård I, Kjellgren D, et al. Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol. Br J Ophthalmol 1995;79:12-16.
2. Alm A, Stjernschantz J, the Scandinavian Latanoprost Study Group. Effects on intraocular pressure and side effects of 0.005% latanoprost once daily, evening and morning. A comparison with timolol. Ophthalmology 1995; 102:1743-52.
3. Camras CB, the United States Latanoprost Study Group. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma. A six-month, masked, multicenter trial in the United States. Ophthalmology 1996; 103:138-47.
4. Watson P, Stjernschantz J, the Latanoprost Study Group. A six month randomized double-masked study comparing latanoprost to timolol in open angle glaucoma and ocular hypertension. Ophthalmology 1996;103:126-37.
5. Mishima HK, Masuda K, Kitazawa Y, et al. A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study. Arch Ophthalmol 1996;114:929-39.
6. Camras CB, Alm A, Watson P, et al. Latanoprost, a prostaglandin analog, for glaucoma treatment. Efficacy and safety after one year of treatment in 198 patients. Ophthalmology 1996;103:1916-24.
7. Watson PG, the Latanoprost Study Group. Latanoprost -two years' experience of its use in the United Kingdom. Ophthalmology 1998;105:82-7.
8. 2α analogue. Adv Prostaglandin Thromboxane Leukot Res 1995; 23:513-8.
9. 2α analogue, on aqueous humor dynamics in human eyes. Ophthalmology 1993;100:1297-304.
10. 2α analogue, after topical application in normal and ocular hypertensive human eyes. Arch Ophthalmol 1993;111:1351-8.
11. 2α-isopropylester to timolol in patients with open angle glaucoma. A randomized, masked placebo-controlled study. Arch Ophthalmol 1990;108:1102-5.
12. Lee PY, Shao H, Camras CB, et al. Additivity of prostaglandin isopropyl ester to timolol in glaucoma patients. Ophthalmology 1991;98:1079-82.
13. Uusitalo RJ, Palkama A. Long-term evaluation of timolol. Acta Ophthalmol 1989;67:573-81.
14. Weinreb RN. Compliance with medical treatments of glaucoma. J Glaucoma 1992;1:134-6.
15. Boger WP III, Puliafito CA, Steinert RF, et al. Long-term experience with timolol ophthalmic solution in patients with open-angle glaucoma. Ophthalmology 1978;85:259-67.
16. Schlecht LP, Brubaker RF. The effects of withdrawal of timolol in chronically treated glaucoma patients. Ophthalmology 1988;95:1212-6.
17. Söderström MB, Wallin Ö, Granström P-A, et al. Timololpilocarpine combined vs timolol and pilocarpine given separately. Am J Ophthalmol 1989;107:465-70.